PG Versus TG for Advanced PGC

National Taiwan University Hospital96 enrolled

Overview

We conducted a retrospective study on patients with pathological stage II-III PGC who underwent PG or TG from 2013 to 2023. Propensity score-matching was applied to adjust for tumor size and stage between the PG and TG groups at a 1:1 ratio. We evaluated the procedural safety, oncological, and functional outcomes.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Gastric Adenocarcinoma Gastrectomy

Interventions

proximal gastrectomyPROCEDURE

proximal gastrectomy

total gastrectomyPROCEDURE

total gastrectomy

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Proximal gastric adenocarcinoma after total or proximal gastrectomy. Exclusion Criteria: * Non-curative resections * Non-adenocarcinoma histology * Distally located tumors or middle/proximally located tumors for which distal margin could not be secured by PG * Remnant gastric cancer * Clinically T1N0 tumors smaller than 3 cm for which PG was clearly indicated

Locations (1)

National Taiwan University Hospital Hsin-Chu Branch

Hsin-Chu County, Taiwan

Outcomes

Primary Outcomes

five-year overall survival

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.